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Received: 10.11.2011

•

Accepted: 28.04.2012

•

Published Online: 24.10.2013

•

Printed: 18.11.2013

Abstract: Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly. The
aim of this study was therefore to explore the relationship between the presence of multiple gene polymorphisms and 2
distinct advanced ‘dry and wet’ AMD phenotypes, and to assess gene interactions with the influence of personal factors
in a Turkish population as a pilot study.
For the analysis, the data were collected from 73 unrelated participants, grouped as 29 wet and 26 dry AMD
patients, and 18 healthy controls. They were all genotyped for the multiple gene polymorphisms in 12 different genes.
The data set collected was then analyzed using the Bayesian inference methods and visualized by means of the Bayesian
networks.
The results suggest that: 1) the PAI-1 4G/5G and FV G1691A genes have joint roles in the separation of the 3
groups; 2) both wet and dry AMD can be separated from the control group using the genes PAI-1 4G/5G, FV G1691A,
FXII V34L, and PT G20210A; 3) although the wet AMD and control groups can be separated by the combination of
the ACE I/D and B-fibrinogen-455 G-A gene polymorphisms, there seems to be no significant effect of the genes on
the separation between the dry AMD and control groups; 4) the wet AMD and control groups can be distinguished by
the combination of body mass index and the MTHFR-C677T and PAI-1 genes; and 5) there is a correlation between
wet AMD and a high body mass index ( > 30 kg/m 2 ) . It was also found that the impact of body mass index on the
disease development seems only in question with the connective availability of the genes MTHFR C677T and PAI-1. It
can be concluded that the combination of the MTHFR C677T and PAI-1 4G/5G gene polymorphisms in the presence
of obesity may increase the risk of wet AMD. In addition, the results further support a complex interplay among genetic
and environmental factors in the development of different phenotypes.
Key words: Age-related macular degeneration, body mass index, MTHFR C677T, PAI-1 4G/5G, gene–gene interaction,
Bayesian network
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1. Introduction
Age-related macular degeneration (AMD) is a leading cause of legal blindness among older individuals, most
often from industrialized countries [1]. Phenotypically, AMD is classified as ‘early’ and ‘late’, which is based
on clinical features [2,3]. Late AMD is considered as a disease with 2 different end-stage lesions, i.e. wet and
dry. Deposition of debris (termed ‘drusen’) along Bruch’s membrane in the macula is the first evidence of early
AMD. An increasing number of large drusen tends to develop in 2 different ways. In the late ‘dry’ AMD, a
geographic loss of retinal pigment epithelium (RPE) occurs in the macular region, while in the late neovascular
or ‘wet’ form of the disease, there is abnormal growth of the choroidal vessels under the retina, which leak fluid
and may progress to form a disciform scar [4–6]. Dry AMD has a slower deterioration and better preservation
of visual acuity than wet AMD. The neovascular AMD is rapid and the loss of vision is often very severe.
The genetic structure and individual risk factors that lead to these diverse phenotypes are currently under
investigation. However, it is widely believed that the pathogenesis responsible for AMD is linked to external
factors and varying susceptibilities to these external factors may be based upon different genetic backgrounds
[7]. The major genetic risk factors for AMD, including the Complement Factor H and HTRA1 variants, appear
to predispose to both dry and wet AMD [8,9]. Along with genetic variants, external factors such as age, smoking,
sex, and body mass index (BMI) play major roles in the disease pathogenesis [10,11].
It is still not understood why an individual at risk will manifest dry or wet AMD and which factors
or interactions can trigger the progression of the maculopathy. The etiology of AMD is complex and the
prevalence of both AMD and cardiovascular disease (CVD) is strongly age-dependent. The aim of the present
study was therefore to explore the relationship between the presence of multiple gene polymorphisms related to
cardiovascular risk factors and the 2 distinct advanced ‘dry and wet’ AMD phenotypes, and also to assess the
gene interactions with personal factors.
2. Materials and methods
2.1. Study population
This study was planned as a prospective case-control study. Informed consent was obtained from each of the
participants, and the procedures used conformed to the principles of the Declaration of Helsinki. Patients with
AMD (dry and wet) and age-matched controls were recruited from the outpatient clinic at the Department of
Ophthalmology, İzmir Education and Research Hospital. None of the AMD or control subjects were related to
each other. Both the AMD patients and the control subjects underwent full ophthalmological examinations,
including slit-lamp biomicroscopy, fundoscopy, and contact lens biomicroscopic examination of the macula.
All eyes with AMD exhibited multiple drusen, geographic atrophy, choroidal neovascular membranes, and
vascularized pigment epithelial detachments, but the control subjects did not have any of these signs. Those
patients with multiple drusen, geographic atrophy, or both were classified as having dry AMD, but patients
with a previous history or any other clinical signs of other macular diseases were not included in the present
study. Patients with choroidal neovascular membranes, vascularized pigment epithelial detachments, or both
were classified as having wet AMD [12]. Fluorescein and indocyanine green angiography, using a scanning laser
ophthalmoscope, was applied to all AMD patients. Choroidal neovascularization was defined as irregular or
well-delineated focal or plaque-like zones of indocyanine green hyperfluorescence that persisted or increased in
the late phases of the videoangiogram [13]. Cataract patients with no signs of AMD were used as controls.
The control group patients had healthy macula and these patients had no diabetes mellitus or hypertension
(HT). In the examinations, detailed medical and family histories were obtained from the patients. The patients
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ÇELEBİLER et al./Turk J Elec Eng & Comp Sci

and controls filled in a questionnaire about their personal histories (age, sex, essential HT, CVD, diabetes
mellitus, smoking habits, overweight, and family medical history). The presence of traditional risk factors in
both groups was determined with the criteria standardized and endorsed by the European Society of Cardiology,
and a hypertensive condition was attributed when the systolic blood pressure values were ≥ 139 mmHg and/or
diastolic blood pressure values were ≥89 mmHg in at least 2 separate measurements or when being medicated
against HT. The subjects were considered as smokers when consuming more than 5 cigarettes per day or
nonsmokers when they had never smoked or had stopped smoking at least 1 year before the sample collection.
The BMI was calculated as the weight in kilograms divided by the height in squared meters.
Seventy-three unrelated participants, grouped as 29 wet AMD patients (58–87 years old; mean: 73 ± 8.0
years), 26 dry AMD patients (49–84 years old; mean: 71 ± 10.3 years), and 18 healthy controls (54–89 years
old; mean: 69 ± 9.0 years), were included in the present study. The other demographic characteristics of the
groups are given in Table 1.
Table 1. The demographic characteristics of the groups (n: number of participants).

Demographic characteristics
Men
Sex
Women
Yes
Smoking
No
18.6–4.9
25–29.9
BMI (kg/m2 )
30–39.9
> 40
Negative
History of HT
Positive
Negative
History of CVD
Positive
∗

Wet AMD (n)
10
19
23
6
3
8
16
2
13
16
19
10

Dry AMD (n)
9
17
23
3
12
10
4
11
15
16
10

Control (n)
6
12
12
6
9
6
3
7
11
14
4

P-value*
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS

The nominal variables were compared between the AMD patients and the controls using the chi-square analysis, whereas

Fisher’s test was used for rare variables where the chi-square test was unsuitable.
NS = not significant.

2.2. Data generation by genotyping
Approximately 10–20 µ g of DNA was isolated from peripheral blood samples using the spin column technique
(genomic DNA extraction kit; RBC Bioscience, Taipei, Taiwan). The DNA concentration and purity was
measured with a UV spectrophotometer (UV-3600; Shimadzu, Kyoto, Japan). The following 12 polymorphisms
were evaluated: 2 polymorphisms of the factor V gene (FV G1691A and FV A4070G), 1 polymorphism of
the factor II gene (PT G20210A), 1 polymorphism of the factor XIII gene (FXIII V34L), 1 polymorphism of
the beta-fibrinogen gene ( B -fibrinogen 455 G-A), 1 polymorphism of the platelet glycoprotein IIIA gene (HPA
L33P ), 1 polymorphism of the plasminogen activator inhibitor-1 gene (PAI-1 4G/5G), 2 polymorphisms of
the methylenetetrahydrofolate reductase gene (MTHFR C677T and MTHFR A1298C ), 1 polymorphism of the
angiotensin-converting enzyme gene (ACE I/D), and 2 polymorphisms of genes encoding for apolipoproteins B
and E (Apo B R3500Q and Apo E2, E3, and E4, respectively). These 12 polymorphisms were analyzed using a
commercially available kit (Cardiovascular Disease StripAssay; ViennaLab Labordiagnostika, Vienna, Austria),
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according to the manufacturer’s instructions. All of the results were confirmed with double replicates. This
assay was based on the multiplex polymerase chain reaction and reverse hybridization principle. Table 2 shows
the distribution of the genotypes and allele frequencies in wet and dry AMD patients and the control group.
Mutant alleles of ApoB R3500Q were not found in any case of the patients or controls. Therefore, this mutation
was excluded from further analysis. The nominal variables and allele frequencies were compared between the
AMD patients and the controls using chi-square analysis. However, Fisher’s test was utilized for rare variants
where the chi-square test was unsuitable. Statistical analyses were performed using the SPSS 10.0 and P <
0.05 was considered to be statistically significant.
2.3. Bayesian inference method
Bayesian networks (BNs) are known as directed acyclic graphs and are effectively used for knowledge representation by exploiting cause-and-effect relationships even in uncertain conditions. BNs are also called ‘directed
Markov fields’ or ‘belief networks’ [14] and are the probabilistic models in which Bayesian inference methods
are used for graphical knowledge representation. In a BN, each node graphically represents an attribute and is
called a variable (e.g., age, sex, or expression level of a gene). They graphically encode and represent conditional
independence relationships between all or a set of the attributes. In the BNs, connections (arcs) between the
nodes (attributes) represent dependency relationships of the variables. It is well known that different configurations of the directions of the arcs may induce the same independencies. In the configurations, the direction of
the arcs is not uniquely determined. It can therefore not be expected that the arcs actually reflect the direction
of causality, but they show the connections between the related attributes [15].
BNs operate with probabilistic inference methods and hence they reach their decisions from uncertain
data (e.g., not true or false). They can also simultaneously handle discrete and continuous variables without
any need for arbitrary thresholds. In addition, their semantic presentation also makes them advantageous over
other types of classifiers (e.g., artificial neural networks). This type of representation helps display the links
between all of the attributes or stratified set(s) of the attributes. Furthermore, it has been shown that they
can speed up the learning process by attaching prior knowledge (probabilities) to the attributes and cause less
problems in noise and overfitting [14,15]. Therefore, a BN was chosen in this study to investigate and display the
relationship between the presence of multiple gene polymorphisms and 2 distinct advanced ‘dry and wet’ AMD
phenotypes, and to assess and visualize the gene interactions with the influence of personal factors. Further
information about the BN can be found in [14].
The specification of the attributes used in this study is summarized in Tables 1 and 2. The data set
used in the BNs included 11 types of genes, which are called attributes, as listed in Table 2. In addition, 6
more attributes, as listed in Table 1, were included in the analysis in order to assess the effects of personal
information.
In this work, the BN software packages PowerCostructorTM and PowerPredictorTM were used for the network construction and classification processes, respectively, where both utilities were based on ‘the dependency
analysis’ [16]. The statistical algorithms examine the network information regarding 2 related variables of the
data set and decide whether they are dependent or not. The algorithms also examine how strong the relationships between the 2 variables are. For the construction of the BN, the threshold value (t) was set at minimum,
namely 0.1, in order to establish the maximum number of links within the network. In addition, the receiver
operating characteristic (ROC) was chosen to determine the optimum models. No discretization method was
selected, as there was no continuous variable in the data set under study.
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Table 2. Genotype and allele frequencies of the genetic polymorphisms in the participants.
Polymorphism
Wet AMD (n: 29)
Dry AMD (n: 26)
F 5 (FV Leiden) c.1691G > Aa (rs6025c)b
GG
25
26
GA
4
AA
A allele frequency
0.069
0
F 5 (R2) c.4070A > Ga (rs1800595)b
AA
23
23
AG
6
3
GG
G allele frequency
0.104
0.058
F 2 (Prothrombin) c.20210G > Aa (rs1799963)b
GG
28
25
GA
1
1
AA
A allele frequency
0.017
0.019
F 13A1 (FXIII) c.143G > Ta (rs5985)b
VV
19
18
VL
10
5
LL
3
L allele frequency
0.172
0.212
FGB (Fibrinogen) c.455G > Aa (rs1800790)b
GG
21
14
GA
8
10
AA
2
Aallele frequency
0.138
0.269
SERPINE 1 (PAI-I) c.675-676delinsGa (rs1799889)b
5G/5G
9
5
5G/4G
11
17
4G/4G
9
4
4G allele frequency
0.500
0.481
ITGB 3 (GpIIIa) c.176T > Ca (rs5918)b
L/L
21
16
L/P
7
7
P/P
1
3
P allele frequency
0.155
0.250
MTHFR c.677C > Ta (rs1801133)b
CC
11
17
CT
13
8
TT
5
1
T allele frequency
0.397
0.192
MTHFR c.1298A > Ca (rs1801131)b
AA
11
10
AC
17
12
CC
1
4
C allele frequency
0.328
0.385
ACE g.11417 11704del287a (rs4646994)b
I/I
5
7
I/D
13
9
D/D
11
10
D allele frequency
0.603
0.558
APOE c.388T > Ca (rs429358)b c.526C > Ta (rs7412)b
2/3
5
4
3/3
20
20
3/4
4
2
E3 allele frequency
0.844
0.884

Control group (n: 18)

P-value*

15
3
0.083

NS

14
4
0.111

NS

15
3
0.083

NS

10
7
1
0.250

NS

12
5
1
0.194

NS

2
15
1
0.472

NS

9
8
1
0.277

NS

9
8
1
0.277

NS

10
7
1
0.250

NS

7
7
4
0.416

NS

3
12
3
0.833

NS

∗
Allele frequencies were compared between the AMD patients and the controls using chi-square analysis. For rare
variants for which the chi-square test was unsuitable, we utilized Fisher’s test. NS = not significant.
a
Nomenclature according to the Human Genome Variation Society names in the Single Nucleotide Polymorphism
Database (dbSNP) - National Center for Biotechnology Information, b : dbSNP ID.
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2.4. Dependency analysis in the BN
The dependency analysis examines the information of 2 related nodes from any given data set and decides if
the 2 nodes are dependent or not and how close their relationship is. This information is called the conditional
mutual information of 2 nodes, A i and A j , and can be denoted as:
I(Ai , Aj |C) =

∑
ai ,aj ,c

P (ai , aj , c) log

P (ai , aj |c)
,
P (ai |c)P (aj |c)

where C is a set of nodes and c is a vector (1 instantiation of the variables in C). If I(Ai ,Aj |C ) is smaller than
a certain threshold t, then it can be concluded that Ai and Aj are conditionally independent. The selection
of a threshold value for t depends on the data set under study and may be between 0.1 and 50 [16]. The values
of P (ai , aj |c ) may be extracted from the conditional probability tables. For this study, the threshold value
(t) was set at minimum, namely 0.1, in order to establish the maximum number of links within the network
and consequently investigate the different aspects of the interactions between all of the variables, including the
personal information and multiple gene polymorphisms.
3. Results
In order to establish the true nature of the relationship between the attributes and discover a robust set
of associative attributes, various scenarios were taken into consideration and analyzed under the following 4
investigations. Each case study presented in the following subsections refers to a modular approach of the
Bayesian inference technique. The data inference stages fall into these 4 categories, for each of which a different
BN was constructed. This method is called a modular approach because a particular network is built for each
case. It should be noted that each network is specific to a particular task and aimed at unveiling different
characteristics of the case studies as well as the relationship between the attributes associated with the disease.
The overall results of sensitivity, specificity, and accuracy are presented in Tables 3, 4, and 5. They can
be formulated depending on the investigation type. For example, they can be calculated for Investigation 2 as:
Sensitivity = (number of correctly classified wet AMD samples / number of all wet AMD samples).
Specificity = (number of correctly classified control group samples / all control group samples).
Accuracy = (number of all correctly classified samples / number of all the samples in the data set).
They can also be formulated similarly for all of the other investigations.
In order to present a generalization ability of the BN models constructed, a 5-fold cross-validation method
was adapted, where the data set was divided into 5 subsets, each containing more or less 20% of the samples.
Four of these 5 subsets were used first for training a BN-based model, and the BN-based model was then tested
over the remaining subset. The procedure was repeated until all of the subsets were tested.
3.1. Investigation 1: General view of the BN configuration with all of the attributes
In this BN, all 3 groups and attributes were included for a network configuration in order to extract the
general characteristics of the data set collected. As a result, some remarkable conclusions were observed,
such as that a link between smoking and ACE I/D polymorphism can be established, as shown in Figure 1.
In addition, a connection between the class node group and the genes PAI-1 4G/5G and FV G1691A was
observed. Furthermore, the network configuration appears to indicate that HT is not directly connected to any
genetic attribute but only connected to CVD.
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HT

HPA1

FV H1299R
Sex
CVD

B-fibrinogen-455 G-A

Smoking
PT G20210A
MTHFR A1298C
ACE

FV G1691A

PAI-1
MTHFR C677T

FXIII V34L

ApoE

Group

Age

Figure 1. General view of the BN configuration with all of the attributes and groups. It should be noted that in all of
the network configurations, the direction of the arcs was determined by the available node ordering and hence does not
necessarily show the direction of potential causality.

3.2. Investigation 2: The role of all of the genes in separation between wet AMD patients and
control group
This network module was constructed to investigate the effects of the genes on the separation between the wet
AMD and control groups, and also to see if there is any genetic difference between the groups with and without
the retinopathy disease. The analysis resulted in the BN presented in Figure 2, yielding a predictive accuracy
of 83.3%, as shown in Table 3. The ROC area under curve (AUC) measure of the accuracy values and confusion
matrix are also shown in Table 4. In Table 4, the AUC indices show the measure of the test’s accuracy, which
were found to be sensitivity of 89.6% (1 – false control rate) and specificity of 93.5% (1 – false wet AMD rate).
The lift index indicates the ratio between the results predicted using the classification model and the results
using no model (predicted randomly).
FV G1691A
FXIII V34L
ACE

B-fibrinogen-455 G-A

PT G20210A
HPA1
PAI-1
Group
MTHFR C677T

FV H1299R

MTHFR A1298C

ApoE

Figure 2. The BN for Investigation 2. After the network construction, the links were established between 2 genes (ACE
I/D and B-fibrinogen-455 G/A) and the class node ‘Group’ that included the wet AMD and control groups.
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Table 3. Predictive accuracy results for all of the investigations.

Investigation 2

Investigation 3

Investigation 4

BN model for:

Sensitivity
(%)

Specificity
(%)

Investigating the role of all of
the genes in separation
between the wet AMD
patients and the
healthy/control groups
Investigating the role of all of
the genes in separation between
the AMD patients (wet and dry
AMD) and the healthy/control
groups
AMD (wet AMD) and the
healthy/control groups

81.8

85.7

Overall accuracy %
(±standard error %) at a
95% confidence level
83.3 (±4.7)

85.7

25.0

69.0 (±7.0)

83.3

75.0

80.0 (±2.5)

Table 4. For Investigation 2, classification results of the wet AMD patients and the healthy/control group. ROC:
receiving operating curve, AUC: area under curve.

For Investigation 2
Classification of the wet AMD patients and control
group
Confusion matrix
Wet AMD Control Lift index
Wet AMD
9
2
0.681
Control group 1
6
0.793
ROC (AUC) indices
Wet AMD Control
Wet AMD
0.000
0.935
Control group 0.896
0.000
3.3. Investigation 3: The role of all of the genes in separation between the AMD patients (wet
and dry AMD) and control group
This investigation was carried out similarly to Investigation 2. However, the wet and dry AMD groups were
merged and matched against the control group for this case, in order to see which attributes are associated with
AMD in general. The investigation appears to indicate that the AMD patients can be separated easily from
the control group by a predictive accuracy of 69% (Table 3). This analysis also generated the BN with the joint
roles of the genes PAI-1, FXIII V34L, FV G1691A, and PT G20210A, as shown in Figure 3. The ROC (AUC)
measure of the accuracy values and confusion matrix are also shown in Table 5. In Table 5, the AUC indices
show the measure of the test’s accuracy, which were found to be sensitivity of 53% (1 – false control rate) and
specificity of 53.7% (1 – false AMD rate). The lift index indicates the ratio between the results predicted using
the classification model and results using no model (predicted randomly).
3.4. Investigation 4: The role of high BMI in wet AMD development
The role of BMI in separation between the wet AMD and control groups was investigated to identify a possible
association between BMI and wet AMD. The investigation process was pursued in 2 stages. At the first stage,
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the attribute ‘Group’ was taken as a class node in the BN classifier to prove the casual effect of BMI on the group
separation. This classification process resulted in a predictive accuracy of 80% and a BN with the connections
between the ‘Group’ node and the BMI, MTHFR C677T, and PAI-1 4G/5G nodes, as depicted in Figure 4. In
the second stage, the wet AMD and control groups were taken as the attribute set in the network and the BMI
was divided into 2 categories, as normal (BMI n < 30 kg/m 2 ) and high (BMI h ≥ 30 kg/m 2 ) , and this was
examined to see whether there is a direct link between the high BMI and the wet AMD group. As seen in Figure
5, the link was established after the process between the 2 nodes. In the network, the exclusion of a direct
link with PAI-1 4G/5G may be ignored as a specific case; namely, a connection between only the wet AMD
group and high BMI was examined. In addition, the link between the wet AMD and control groups may be
ignored since it is inevitable, as they already have a limited correlation. It should be noted that the important
point is that BMI was included in the network only in Investigation 4. Therefore, the separation processes of
Investigations 1, 2, and 3 are not comparable to that of Investigation 4.
HPA1

FV H1299R

B-fibrinogen-455 G-A

ACE

FV G1691A

MTHFR C677T

MTHFR A1

PT G20210A

FXIII V34L

ApoE
298C

PAI-1

Group

Figure 3. The BN for Investigation 3. The links were established between the class node ‘Groups’ that included the
control group and both the wet and dry AMD groups.
Table 5. For Investigation 3, the classification results of the AMD patients (wet and dry AMD) and the healthy/control
group.

For Investigation 3
Classification of the AMD patients (wet and dry
AMD) and the healthy/control group
Confusion matrix
AMD Control Lift index
Wet AMD
2
1
0.525
Control group 7
0
0.545
ROC (AUC) indices
AMD Control
AMD patients 0.000 0.537
Control group 0.530 0.000
4. Discussion
The most recent advances in gene discovery clearly indicate that AMD has a close link with the interaction
of multiple genetic and environmental factors [17]. However, it remains unanswered as to why some patients
develop dry AMD while others develop the wet form of the disease. In the last few decades, nonlinear classifiers
like BNs have been in very high demand for an accurate and reliable analysis of such medical data sets, which
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may contain a considerable amount of uncertainty (e.g., uncertainty in clinical observations or test results).
In recent years, a number of research projects have been carried out to exploit the BNs for various types
of data analysis and decision making [18–25]. Even though the previous works investigated and developed
the Bayesian inference models theoretically, a few of them actually exploited the semantic characteristics of
the BNs to derive highly specific information from the links between the attributes. In the proposed work,
different types of (modular) BNs for each specific investigation were constructed to investigate and display
the relationship between the presence of multiple gene polymorphisms and 2 distinct advanced ‘dry and wet’
phenotypes of AMD, and to assess and visualize the gene interactions with the influence of personal factors.
Each BN that corresponds to a different combination of these cases and attributes can help us to observe effects
of various combinations of the attributes on the disease. With this highly specified analysis, where more specific
cause-and-effect relationships can be established within the network, the exact role or impact of the genes was
studied.
MTHFR A1298C
ApoE

FXIIIV34L

PT G20210A

FV H1299R
FV G1691A

FV H1299R

PT G20210A MTHFR A1298C

ACE

HPA1

PAI-1

B-fibrinogen - 455 G -A FV G1691A
HPA1

FXIII V34L

ApoE

MTHFR C677T

B-fibrinogen-455 G-A

ACE

MTHFR C677T

BMI_h
BMI_n

BMI

PAI -1
Control group
Wet type AMD

Group

Figure 4. The BN for Investigation 4. The network was
constructed with the links between the BMI, 2 genes, and

Figure 5. Specific case of the BN for Investigation 4
resulting in a link between the high BMI and wet AMD

the Group class node (wet AMD and control groups) that

(dashed line).

yielded a predictive accuracy of 80%.

It should be noted that the classification process differs from the network construction process, as each
one is processed by different utilities of the BN. In the classification process, the priority is given to a model with
a more accurate classification, and hence only an optimal group of the attributes were included in the network.
As shown in Figure 2, most of the attributes were excluded, not because all of them were unimportant, but
because they would not make any further contribution towards the classification accuracy. On the other hand,
in the network construction process, the priority is given to discovering more possible connections between the
attributes, in which case no class node is selected. The connections between the attributes were analyzed by
setting a minimum threshold of t at 0.1 in order to assess all of the possible connections between the attributes.
As far as the clinical tasks of the research are concerned, during normal hemostasis, there is a balance
between coagulation and fibrinolysis. Inherited clotting abnormalities such as the FV G1691A mutation and PT
G20210A gene polymorphism are related to unbalanced hemostasis [26,27], and hence the thrombotic tendency.
PAI-1 is the major inhibitor of fibrinolysis. The 4G/5G polymorphism in the PAI-1 gene promoter region is
associated with a higher plasma PAI-1 activity [28]. Elevated plasma concentrations of PAI-1 are associated
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with early atherosclerosis [29] and are predictive of mortality after myocardial infarction [30]. In this research,
the result of Investigation 1 was the network construction process, which showed that the PAI-1 4G/5G and FV
G1691A genes have joint roles in the separation of the 3 groups (wet AMD, dry AMD, and the control group),
as depicted in Figure 1. In addition, in Investigation 3, both AMD cases (wet and dry AMD) can be separated
from the control group in association with the joint roles of the genes PAI-1 4G/5G, FV G1691A, FXII V34L,
and PT G20210A, and the results are depicted in Figure 3 and summarized in Table 3. Although the role
of these genes in the pathogenesis of AMD is unknown, the findings of the analyses can be interpreted such
that the combination of PAI-1 4G/5G, FV G1691A, FXII V34L, and PT G20210A genes may be related to a
common risk and represent a characteristic feature shared by both the wet and dry AMD groups. However, it
should be noted that this analysis requires further investigation and refinement, as the BN-based model appears
biased towards the control group.
In the study, a link between the attribute ‘smoking’ and the gene ACE I/D polymorphism was established. A similar connection was also proven in a previous study [31], as Busquets et al. suggested that ACE
I/D polymorphisms are associated with the smoking history of an individual. In addition, although the wet
AMD and control groups were shown to be able to be separated from each other using the combination of the
ACE I/D and B-fibrinogen-455 G-A gene polymorphisms (Figure 2; Table 3), no significant effect of the genes
on the separation between the dry AMD and control groups was observed.
Angiotensin-converting enzyme (ACE) is an enzyme known to catalyze the conversion of angiotensin I
to angiotensin II and to deactivate the bradykinin [32]. The ACE gene contains a polymorphism based on the
presence (insertion [I]) or absence (deletion [D]) within an intron of the 287-bp nonsense DNA domain [33]. The
insertion allele of the ACE gene is associated with lower ACE activity in the bloodstream and in the tissues
[34]. The ACE I/D gene polymorphism was shown to affect angiogenesis [35]. The ACE I /I genotype has
been found at higher frequencies in the normal than in the dry AMD, and a possible protective role of the
polymorphism against the dry form of AMD was suggested [36]. According to a previous study, lower ACE
activity enhances the retinal endothelial cell survival in tissue culture [37]. Kostamaa et al. suggested that
the insertion allele leads to an enhancement in the endothelial cell survival by ACE inhibition, leading to a
predisposition for neovascular AMD [38].
Fibrinogen is a hemostatic factor and acute phase proinflammatory protein. Several studies showed that
the A allele of the -455 G/A polymorphism in the fibrinogen β chain promoter region is associated with an
elevated plasma fibrinogen concentration [39,40]. Epidemiological studies have reported a relationship between
fibrinogen and AMD [41,42]. It has also been suggested that extravasated fibrinogen might play an important
role in the development of the choroidal neovascularization associated with AMD, at least in part, through the
function of the vascular endothelial growth factor in an autocrine manner [43].
At this stage, our findings may implicate different mechanisms of the AMD progression. In addition, the
results highlight the association of multiple gene polymorphisms with different phenotypes of AMD. A genetic
background including the ACE I / D and B-fibrinogen-455 G-A polymorphisms may mediate the progression to
the wet form of early AMD. Considerable vision loss can also result from the features associated with dry AMD,
but serious vision loss occurs much more rarely than with wet AMD. The development of effective treatments
that reduce the risk of further vision loss and prevent legal blindness makes it more important to predict wet
AMD at an early stage so that patients can be treated quickly. Therefore, the prediction of progression of wet
AMD is an important effort.
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One of the most interesting outcomes of this research is the discovery of the role of BMI in separation
between the wet AMD and control groups. In order to reach this conclusion, whether a high BMI may have an
effect on developing wet AMD was investigated. At the first stage, the wet AMD group was separated from the
control group by the combination of BMI and the MTHFR-C677T and PAI-1 genes (Figure 4). At this stage,
it was proven that: 1) the wet AMD group was separated from the control group by a predictive accuracy of
80% and 2) there was a causal link between BMI and at least 1 of the groups, and hence a possible link with
AMD. At the second stage, the findings also showed a connection between the wet AMD group and a high BMI
(>30 kg/m 2 ) (Figure 5). It should be noted that the impact of BMI on the disease development is only in
question with the connective availability of 2 genes, MTHFR C677T and PAI-1.
Overweight and obesity are significantly associated with diabetes, high blood pressure, high cholesterol,
arthritis, and poor health status [44]. The results from the Blue Mountains Eye Study also suggested an
increased risk for the onset of early or dry AMD among individuals outside the normal BMI range [41]. Another
study found a relationship between late AMD and pigmentary abnormalities, and a BMI of greater than 30,
compared with lean individuals [45], and the Beaver Dam Eye Study also found a significant relationship between
BMI and early AMD for women, but not for men [46]. The Age-Related Eye Disease Study also showed that a
higher BMI was associated with the prevalence of neovascular AMD [47].
An increased level of PAI-1 has been shown to be associated with obesity and BMI [48]. Moreover,
recently increasing evidence demonstrated a proangiogenic role of PAI-1 [49]. In addition, a dose-dependent
effect of PAI-1 has been reported in vitro [50] and in vivo in a model of choroidal neoangiogenesis [51].
The C677T polymorphisms in the MTHFR gene have been shown to decrease the enzymatic activity,
resulting in elevated plasma homocysteine levels [52]. Some studies have shown increased plasma homocysteine
in patients with AMD [53]. Another study reported that there were no differences in the plasma homocysteine
or folate concentrations in those with wet AMD compared to those with dry AMD [54]. It was also suggested
that the MTHFR C677T gene polymorphisms are the genetic risk factors for obesity [55].
The results presented in this study suggest that the combination of the MTHFR C677T and PAI-1 4G/5G
gene polymorphisms in the presence of obesity (BMI of greater than or equal to 30 kg/m 2 ) may increase the
risk of wet AMD. A different study reported that increasing physical activity, improving the diet, and sustaining
these lifestyle changes can reduce both the body weight and the risk of diabetes [44]. In this context, weight loss
may make it possible to delay or prevent the progression of wet AMD in susceptible individuals. The strengths
of our study include its prospective analysis of homogeneous groups of different phenotypes of AMD. To the best
of our knowledge, this is the first study that demonstrates the combined effect of multiple gene polymorphisms
and BMI in the separation of wet AMD from healthy individuals. Having said that, the results support that
the manifestation of different phenotypes characteristics in AMD is the result of a complex interplay among
genetic and environmental factors. In addition, it is also shown that the progression of AMD, like with many
chronic conditions, cannot be explained by a single genetic or environmental risk factor. However, it should be
noted that the size of the studied subject population was relatively small and therefore larger-scale prospective
studies are needed to confirm these findings.
As a final remark, the study shows how the BNs and their graphical representation of the attributes’
connection are suited to such a complex medical problem that involves genetic and individual factors.
In this paper, the combined effects of the genes and the individual risk factors in the 2 main subtypes
of AMD (dry and wet) and the controls were investigated using the BNs. Different types of (modular) BNs
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for each specific investigation were constructed in order to observe the effects of the different combinations
of the attributes on the disease. Through this highly specified analysis, where more specific cause-and-effect
relationships were established within the network, the exact role or impact of various sets of the genes was
investigated. The results reveal for the first time that the combined effect of multiple gene polymorphisms
and BMI was found to be associated with the separation of wet AMD from the healthy individuals. More
specifically, it was discovered that the connection among AMD, the MTHFR C677T and PAI-1 4G/5G gene
polymorphisms, and BMI can be made. Understanding the combined effects and interactions between specific
genotypes and risk factors may therefore help resolve the complex progression of AMD. If preventive strategies
(e.g., weight loss and smoking cessation) become applicable to those who have advanced AMD susceptible gene
variants, the public health threats of blindness could be effectively reduced.

5. Conclusions
In this paper, the relationship between the presence of multiple gene polymorphisms and 2 distinct advanced ‘dry
and wet’ AMD phenotypes was studied and the interactions of the genes with the influence of personal factors
were also assessed, specifically by taking into account a Turkish population. The computational analysis was
carried out using the BN for not only developing the predictive model but also for visualizing the relationships
and interactions between the attributes.
The outcome of the study reveals that the PAI-1 4G/5G and FV G1691A genes were found to be
discriminative factors that can be used to distinguish the 3 groups (wet and dry AMD, and the control group).
In addition, the genes PAI-1 4G/5G, FV G1691A, FXII V34L, and PT G20210A were found to be associated
with wet and dry AMD, and they can be used to separate the AMD groups from the control group. When
the dry and wet AMD groups were analyzed separately against the control group, although the wet AMD
and control groups could be separated by the combination of the ACE I/D and B-fibrinogen-455 G-A gene
polymorphisms, there seemed to be no significant effect of the genes on the separation between the dry AMD
and control groups. Moreover, the wet AMD and control groups can be distinguished by the combination of
BMI, and the MTHFR C677T and PAI-1 genes. It was also found that there was a correlation between wet
AMD and a high BMI (>30 kg/m 2 ). The impact of BMI on the disease development seems only in question
with the connective availability of the genes MTHFR C677T and PAI-1. This significant outcome highlights
the difference between the dry and wet AMD groups, leading to a breakthrough that is expected to help better
understand the mechanism of the different forms of AMD, as well as aiding in better treatment and patient
management.
This study supports a relationship between life style and AMD, and in particular wet AMD, as a strong
correlation was identified between wet AMD and a high BMI (> 30 kg/m 2 ) . However, it appears to suggest
that the impact of BMI on the disease’s development seems only in question with the connective availability of
the genes MTHFR C677T and PAI-1.
This pilot study can conclude that the combination of the MTHFR C677T and PAI-1 4G/5G gene polymorphisms in the presence of obesity may increase the risk of wet AMD. In addition, the results further support
a complex interplay among genetic and environmental factors in the development of different phenotypes.
In order to further generalize the findings or identify genetic variations over the dry and wet AMD groups,
a collaborative study is under way to collect patient samples from different regions and carry out a comparative
study not only within Turkey, but also across Europe.
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ÇELEBİLER et al./Turk J Elec Eng & Comp Sci

References
[1] D.S. Friedman, B.J. O’Colmain, B. Munoz, S.C. Tomany, C. McCarty, P.T. de Jong, B. Nemesure, P. Mitchell, J.
Kempen, “Prevalence of age-related macular degeneration in the United States”, Archives of Ophthalmology, Vol.
122, pp. 564–572, 2004.
[2] A.G. Caswell, D. Kohen, A.C. Bird, “Retinal pigment epithelial detachments in the elderly: classification and
outcome”, British Journal of Ophthalmology, Vol. 69, pp. 397–403, 1985.
[3] G.S. Hageman, P.J. Luthert, N.H. Victor Chong, L.V. Johnson, D.H. Anderson, R.F. Mullins, “An integrated
hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane
interface in aging and age-related macular degeneration”, Progress in Retinal and Eye Research, Vol. 20, pp. 705–
732, 2001.
[4] M.A. Zarbin, “Current concepts in the pathogenesis of age-related macular degeneration”, Archives of Ophthalmology, Vol. 122, pp. 598–614, 2004.
[5] F.G. Holz, D. Pauleikhoff, R. Klein, A.C. Bird, “Pathogenesis of lesions in late age-related macular disease”,
American Journal of Ophthalmology, Vol. 137, pp. 504–510, 2004.
[6] M.L. Klein, F.L. Ferris 3rd, J. Armstrong, T.S. Hwang, E.Y. Chew, S.B. Bressler, S.R. Chandra, “Retinal precursors
and the development of geographic atrophy in age-related macular degeneration”, Ophthalmology, Vol. 115, pp.
1026–1031, 2008.
[7] R.H. Guymer, E. Heon, A.J. Lotery, F.L. Munier, D.F. Schorderet, P.N. Baird, R.J. McNeil, H. Haines, V.C.
Sheffield, E.M. Stone, “Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with
age-related macular degeneration”, Archives of Ophthalmology, Vol. 119, pp. 745–751, 2001.
[8] D.J. Cameron, Z. Yang, D. Gibbs, H. Chen, Y. Kaminoh, A. Jorgensen, J. Zeng, L. Luo, G. Brinton, J.M. Brand,
P.S. Bernstein, N.A. Zabriskie, S. Tang, R. Constantine, Z. Tong, K. Zhang, “HTRA1 variant confers similar risks
to geographic atrophy and neovascular age-related macular degeneration”, Cell Cycle, Vol. 6, pp. 1122–1125, 2007.
[9] T. Sepp, J.C. Khan, D.A. Thurlby, H. Shahid, D.G. Clayton, A.T. Moore, A.C. Bird, J.R. Yates, “Complement
factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in
smokers and non-smokers”, Investigative Ophthalmology & Visual Science, Vol. 47, pp. 536–540, 2006.
[10] P. Mitchell, J.J. Wang, S. Foran, W. Smith, “Five-year incidence of age-related maculopathy lesions: The Blue
Mountains eye study”, Ophthalmology, Vol. 109, pp. 1092–1097, 2002.
[11] R. Klein, B.E. Klein, S.C. Tomany, S.M. Meuer, G.H. Huang, “Ten-year incidence and progression of age-related
maculopathy: The Beaver Dam eye study”, Ophthalmology, Vol. 109, pp. 1767–1779, 2002.
[12] A.C. Bird, N.M. Bressler, S.B. Bressler, I.H. Chisholm, G. Coscas, M.D. Davis, P.T.V.M. de Jong, C.C.W. Klaver,
B.E.K. Klein, R. Klein, P. Mitchell, J.P. Sarks, S.H. Sarks, G. Soubrane, H.R. Taylor, J.R. Vingerling, The
International ARM Epidemiological Study Group, “An international classification and grading system for agerelated maculopathy and age-related macular degeneration”, Survey of Ophthalmology, Vol. 39, pp. 367–374, 1995.
[13] D.R. Guyer, L.A. Yannuzzi, J.S. Slakter, J.A. Sorenson, P. Hanutsaha, R.F. Spaide, S.G. Schwartz, J.M. Hirschfeld,
D.A. Orlock, “Classification of choroidal neovascularization by digital indocyanine green videoangiography”, Ophthalmology, Vol. 103, pp. 2054–2060, 1996.
[14] J. Cheng, R. Greiner, J. Kelly, D. Bell, W. Liu, “Learning Bayesian networks from data: an information-theory
based approach”, Artificial Intelligence, Vol. 137, pp. 43–90, 2002.
[15] D.S. Touretzky, M.C. Mozer, M.E. Hasselmo, Advances in Neural Information Processing Systems 8, Cambridge,
MA, USA, MIT Press, 1996.
[16] J. Cheng, D. Bell, W. Liu, “Learning Bayesian networks from data: an efficient approach based on information
theory”, Artificial Intelligence, Vol. 137, pp. 43–90, 2002.
[17] X. Ding, M. Patel, C.C. Chan, “Molecular pathology of age related macular degeneration”, Progress in Retinal and
Eye Research, Vol. 28, pp. 1–18, 2009.

2075
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